USE OF METFORMIN IN COMBINATION WITH A GLUCOKINASE ACTIVATOR AND COMPOSITIONS COMPRISING METFORMIN AND A GLUCOKINASE ACTIVATOR

The present invention provides uses of a glucokinase activator in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, improving insulin sensitivity, enhancing phosphorylation of glucose, and improving the therapeutic effectiveness of metformin. The invention al...

Full description

Saved in:
Bibliographic Details
Main Authors VALCARCE-LOPEZ, MARIA CARMEN, MJALLI, ADNAN M.M
Format Patent
LanguageEnglish
French
Published 01.12.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides uses of a glucokinase activator in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, improving insulin sensitivity, enhancing phosphorylation of glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that comprise a GK activator and metformin. The invention also provides a salt formed between metformin and a GK activator.
AbstractList The present invention provides uses of a glucokinase activator in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, improving insulin sensitivity, enhancing phosphorylation of glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that comprise a GK activator and metformin. The invention also provides a salt formed between metformin and a GK activator.
Author VALCARCE-LOPEZ, MARIA CARMEN
MJALLI, ADNAN M.M
Author_xml – fullname: VALCARCE-LOPEZ, MARIA CARMEN
– fullname: MJALLI, ADNAN M.M
BookMark eNrjYmDJy89L5WSoCw12VfB3U_B1DXHzD_L19FMAImd_XydPP8cQT38_hXDPEA8FRwV3n1Bnf2-gIFC5o3OIZ5hjiH-QgqOfC0hxgH-wJ0hxMJgT5Bns6eeOZCJIFQ4TeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvLOjkbmlpamloaOhMRFKABauPTU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate UTILISATION DE LA METFORMINE EN ASSOCIATION AVEC UN ACTIVATEUR DE LA GLUCOKINASE ET COMPOSITIONS COMPRENANT LA METFORMINE ET UN ACTIVATEUR DE LA GLUCOKINASE
ExternalDocumentID CA2799591A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2799591A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:52:46 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2799591A13
Notes Application Number: CA20112799591
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111201&DB=EPODOC&CC=CA&NR=2799591A1
ParticipantIDs epo_espacenet_CA2799591A1
PublicationCentury 2000
PublicationDate 20111201
PublicationDateYYYYMMDD 2011-12-01
PublicationDate_xml – month: 12
  year: 2011
  text: 20111201
  day: 01
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies TRANSTECH PHARMA, INC
RelatedCompanies_xml – name: TRANSTECH PHARMA, INC
Score 2.825786
Snippet The present invention provides uses of a glucokinase activator in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose,...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title USE OF METFORMIN IN COMBINATION WITH A GLUCOKINASE ACTIVATOR AND COMPOSITIONS COMPRISING METFORMIN AND A GLUCOKINASE ACTIVATOR
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111201&DB=EPODOC&locale=&CC=CA&NR=2799591A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1da8Iw8BA3tr1tbmPuizyMvpVZm1Z8KCOmrXasrWh1volpK_hSZXbsbb99l0ydLw5CyMdxkIPLfeTuAvCEt2FumXZDbzQF1ak5R56zWlS3jCzNTYESO5O5w2Fk90b0dWJNKrDY5sKoOqFfqjgiclSK_F6q-3r158RyVWzl-lkscGn54ieOq2Vbd5-BneZ2HK8fuzHXOHc406KB05SFz9oGQ0PpCLXoloz-8sYdmZSy2pco_jkc9xFZUV5AJS9qcMq3H6_V4CTcvHfjcMN660v4Hg09Evsk9BI03MIgIth4HHaC34K25D1IeoSR7tuIx2iTMwSXESJjlsQDwiJXAvfjYaDyhtVkEAyDqLuHUUIdwHAFxPcS3tPxINMd0aac7Y5sXkO1WBb5DRCRi7SRzgxDzAya2VTYbbvdmqFOYaXzOTXrUD-I5vafvTs4U85WFedxD9Xy4zN_QGldikdF5x_JkY9x
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokbwqw9mb4uMfSAPixndxqZsIzCQN0K3kfAyiMz45t_utQLygknT9ONySZtcr3e9-xXgEU_DTFeNhtxoMk3W1DnKnN7SZF1Jk0xlqLFTnjschIY30l4n-qQEi20ujMAJ_RLgiChRCcp7Ic7r1Z8TyxaxlesntsCh5Ysbm7aUbt19ClaS3TGdfmRHVKLUpJYUDswmBz5rKxYaSkd4w37mMPvOuMOTUlb7GsU9g-M-MsuLcyhleRUqdPvxWhVOgs17NzY3ore-gO_R0CGRSwInRsMt8EOChUZBx_8FtCXvfuwRi3R7IxqhTW4hOY8QGVtxNCBWaHPifjT0Rd6w6Az8oR929zhyqgMcLoG4Tkw9GRcy3W3alFq7JatXUM6XeXYNhGUsaSQzRWEzRUsNjRlto92a4Z1CT-ZzTa1B7SCb-j9zD1Dx4qA37fnh2w2cCseriPm4hXLx8ZndoeYu2L3Y8x-tbJJh
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+METFORMIN+IN+COMBINATION+WITH+A+GLUCOKINASE+ACTIVATOR+AND+COMPOSITIONS+COMPRISING+METFORMIN+AND+A+GLUCOKINASE+ACTIVATOR&rft.inventor=VALCARCE-LOPEZ%2C+MARIA+CARMEN&rft.inventor=MJALLI%2C+ADNAN+M.M&rft.date=2011-12-01&rft.externalDBID=A1&rft.externalDocID=CA2799591A1